Up-regulation of Adiponectin by Resveratrol

0301 basic medicine Forkhead Box Protein O1 Pyruvate Dehydrogenase Acetyl-Transferring Kinase Forkhead Transcription Factors AMP-Activated Protein Kinases Protein Serine-Threonine Kinases Up-Regulation Mice 03 medical and health sciences Resveratrol 3T3-L1 Cells Stilbenes Adipocytes Animals RNA Interference Adiponectin RNA, Messenger Protein Multimerization Protein Structure, Quaternary Proto-Oncogene Proteins c-akt Glutathione Transferase Signal Transduction
DOI: 10.1074/jbc.m110.188144 Publication Date: 2010-10-28T00:17:39Z
ABSTRACT
The natural polyphenol resveratrol (RSV) displays a wide spectrum of health beneficial activities, yet the precise mechanisms remain to be fully elucidated. Here we show that RSV promotes the multimerization and cellular levels of adiponectin in 3T3-L1 adipocytes. The stimulatory effect of RSV was not affected by knocking out Sirt1, but was diminished by suppressing the expression levels of DsbA-L, a recently identified adiponectin-interactive protein that promotes adiponectin multimerization. Suppression of the Akt signaling pathway resulted in an increase in the expression levels of DsbA-L and adiponectin. On the other hand, knocking out FOXO1 or suppressing the activity or expression levels of the AMP-activated protein kinase (AMPK) down-regulated DsbA-L and adiponectin. The stimulatory effect of RSV on adiponectin and DsbA-L expression was completely diminished in FOXO1-suppressed and AMPK-inactivated 3T3-L1 adipocytes. Taken together, our results demonstrate that RSV promotes adiponectin multimerization in 3T3-L1 adipocytes via a Sirt1-independent mechanism. In addition, we show that the stimulatory effect of RSV is regulated by both the Akt/FOXO1 and the AMPK signaling pathways. Last, we show that DsbA-L plays a critical role in the promoting effect of RSV on adiponectin multimerization and cellular levels.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (40)
CITATIONS (75)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....